The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Synthetic lethality of LP-184, a next generation acylfulvene, in ex vivo PDX models with homologous recombination defects.
 
Aditya Kulkarni
Employment - Lantern Pharma
Patents, Royalties, Other Intellectual Property - Lantern Pharma
 
Diana Restifo
Research Funding - Lantern Pharma
 
Igor A. Astsaturov
Honoraria - Caris Life Sciences
Consulting or Advisory Role - Caris Life Sciences; Guardant Health
Speakers' Bureau - Caris Life Sciences
Research Funding - Lantern Pharma
 
Umesh Kathad
Employment - Lantern Pharma
Patents, Royalties, Other Intellectual Property - Lantern Pharma
 
Joseph McDermott
Employment - Lantern Pharma
 
Kishor Bhatia
Employment - Lantern Pharma
Leadership - Lantern Pharma
Stock and Other Ownership Interests - Lantern Pharma
Patents, Royalties, Other Intellectual Property - Lantern Pharma
 
Panna Sharma
Employment - Lantern Pharma
Leadership - Lantern Pharma
Stock and Other Ownership Interests - Lantern Pharma
Patents, Royalties, Other Intellectual Property - Lantern Pharma